Opharm is a national leader in medical and protective mask manufacturing. The company was founded in 2020 and operates in the Health Care, Manufacturing, and Pharmaceutical industries. Opharm prides itself on being the leading producer of high-quality IIR medical masks and FFP2 and FFP3 protective masks, with a daily production capacity of over 2.5 million units. Despite the lack of specific information on the headquarters, Opharm's focus on the critical healthcare sector and the demand for protective equipment demonstrates its potential for success in the current market. However, further details about the company's investors and investment history would provide valuable insight into its growth trajectory and future potential.
There is no investment information
No recent news or press coverage available for Opharm.